References
- Lavigne P, Lavigne F, Saliba I. Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Otorhinolaryngol. 2016;273(9):2271–2278.
- Stachler RJ, Chandrasekhar SS, Archer SM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012; 146(3 Suppl):S1–S35.
- Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999; 109(7 Pt 2):1–17.
- Roßberg W, Goetz F, Timm ME, et al. Intratympanic application of triamcinolone in sudden hearing loss—radiologic anatomy in cone beam CT and its’ correlation to clinical outcome. Eur Arch Otorhinolaryngol. 2020; in press.
- Moon IS, Lee JD, Kim J, et al. Intratympanic dexamethasone is an effective method as a salvage treatment in refractory sudden hearing loss. Otol Neurotol. 2011;32(9):1432–1436.
- Lee JB, Choi SJ, Park K, et al. The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2011;268(6):833–839.
- Sun H, Qiu X, Hu J, et al. Comparison of intratympanic dexamethasone therapy and hyperbaric oxygen therapy for the salvage treatment of refractory high-frequency sudden sensorineural hearing loss. Am J Otolaryngol. 2018;39(5):531–535.
- Ahn JH, Yoo MH, Yoon TH, et al. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness? Laryngoscope. 2008;118(2):279–282.
- Hong SM, Park CH, Lee JH. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngol Head Neck Surg. 2009;141(5):579–583.
- Yang HC, Cho YB, Cho HH. Efficacy of concomitant intratympanic steroid injection for sudden deafness according to initial hearing loss. Otol Neurotol. 2015; 36:1604–1609.
- Suzuki H, Hashida K, Nguyen KH, et al. Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy. Laryngoscope. 2012;122(5):1154–1157.
- Suzuki H, Mori T, Hashida K, et al. Prediction model for hearing outcome in patients with idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2011;268(4):497–500.
- Choi Y, Choi HL, Jeong AY, et al. Hyperbaric oxygen (HBO) therapy as an effective approach to the treatment of patients with severe idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2020;140(5):383–386.
- Rang HP, Dale MM, Ritter JM, et al. 21 The endocrine system. In: Rang HP, Dale MM, Ritter JM, Gardner P, editors. Pharmacology. New York (NY): Churchill Livingstone Inc; 1995. p. 417–453.
- Schimmer BP, Funder JW. Chapter 42 ACTH, adrenal steroids, and pharmacology of the adrenal cortex. Section V Hormones and hormone antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman Gilman’s pharmacological basis of therapeutics. 12th ed. New York (NY): McGraw Co; 2011. p. 1209–1235.